White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension

NCT00005316 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

To investigate the mechanisms of white coat hypertension and study it further as a risk factor for heart damage.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1985-12-31
Completion
1995-11-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005316 on ClinicalTrials.gov